HOOKIPA Pharma Inc (HOOK)
3.82
+0.07
(+1.87%)
USD |
NASDAQ |
Nov 05, 10:38
HOOKIPA Pharma Debt to Equity Ratio: 0.00 for June 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.0109 |
| December 31, 2023 | 0.0125 |
| September 30, 2023 | 0.0108 |
| June 30, 2023 | 0.009 |
| March 31, 2023 | 0.0248 |
| December 31, 2022 | 0.0244 |
| September 30, 2022 | 0.0193 |
| June 30, 2022 | 0.017 |
| March 31, 2022 | 0.0348 |
| December 31, 2021 | 0.0559 |
| September 30, 2021 | 0.0454 |
| Date | Value |
|---|---|
| June 30, 2021 | 0.0381 |
| March 31, 2021 | 0.0325 |
| December 31, 2020 | 0.0291 |
| September 30, 2020 | 0.0452 |
| June 30, 2020 | 0.0367 |
| March 31, 2020 | 0.0329 |
| December 31, 2019 | 0.04 |
| September 30, 2019 | 0.0379 |
| June 30, 2019 | 0.0349 |
| March 31, 2019 | -0.0642 |
| December 31, 2018 | -0.0727 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Jun 2024
0.0559
Maximum
Dec 2021
0.0273
Average
0.0291
Median
Dec 2020
Debt to Equity Ratio Benchmarks
| NovaBay Pharmaceuticals Inc | -1.128 |
| Palatin Technologies Inc | 0.00 |
| iBio Inc | 0.0461 |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 125.05M |
| Total Liabilities (Quarterly) | 38.98M |
| Shareholders Equity (Quarterly) | 86.06M |
| Current Ratio | 3.857 |
| Net Debt Paydown Yield | 0.71% |